[{"indications": "Indications\u00a0ventricular arrhythmias, especially\r\nafter myocardial infarction; eye (section 11.7); local anaesthesia (section 15.2)", "name": "LIDOCAINE HYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.3 Anti-arrhythmic drugs", "2.3.2 Drugs for arrhythmias", "Ventricular arrhythmias"], "cautions": "Cautions\u00a0lower doses in congestive cardiac\r\nfailure and following cardiac surgery; monitor ECG and have resuscitation facilities\r\navailable; elderly; interactions: Appendix 1 (lidocaine)", "side-effects": "Side-effects\u00a0dizziness, paraesthesia, or drowsiness (particularly\r\nif injection too rapid); other CNS effects include confusion, respiratory\r\ndepression and convulsions; hypotension and bradycardia (may lead\r\nto cardiac arrest); rarely hypersensitivity reactions\r\nincluding anaphylaxis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2441.htm", "doses": ["By intravenous injection, in patients without\r\ngross circulatory impairment, 100\u00a0mg as a bolus over a few minutes\r\n(50\u00a0mg in lighter patients or those whose circulation is severely\r\nimpaired), followed immediately by infusion of 4\u00a0mg/minute\r\nfor 30 minutes, 2\u00a0mg/minute for 2 hours, then 1\u00a0mg/minute; reduce\r\nconcentration further if infusion continued beyond 24 hours (ECG monitoring\r\nand specialist advice for infusion)", "Following intravenous injection lidocaine has a short duration of action (lasting for 15\u201320 minutes).\r\nIf an intravenous infusion is not immediately available\r\nthe initial intravenous injection of 50\u2013100\u00a0mg can\r\nbe repeated if necessary once or twice at intervals of not less than\r\n10 minutes"], "pregnancy": "Pregnancy\u00a0crosses the placenta but not known to be harmful\r\nin animal studies\u2014use if benefit outweighs risk"}, {"indications": "Indications\u00a0see under Dose; ventricular arrhythmias\r\n(section 2.3.2); eye (section 11.7); oral lesions (section 12.3.1)", "name": "LIDOCAINE HYDROCHLORIDE Lidocaine for surface anaesthesia", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "15 Anaesthesia", "15.2 Local anaesthesia", "Lidocaine", "LIDOCAINE HYDROCHLORIDE", "Lidocaine for surface anaesthesia"], "cautions": "Cautions\u00a0See Cautions of Local Anaesthetics and section 2.3.2; hypertension; topical preparations can damage plastic cuffs of endotracheal\r\ntubes", "side-effects": "Side-effects\u00a0see Toxicity and Side-effects and section 2.3.2; also methaemoglobinaemia (see\r\nunder Prilocaine for treatment), nystagmus, rash; hypoglycaemia\r\nalso reported following intrathecal or extradural administration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/130131.htm", "doses": ["To avoid excessive dosage in obese patients,\r\ndose may need to be calculated on the basis of ideal body-weight", "Infiltration anaesthesia, according to patient\u2019s weight and\r\nnature of procedure, max. 200\u00a0mg (or 500\u00a0mg if given in solutions\r\ncontaining adrenaline)\u2014see also Administration and important warning below", "Intravenous regional anaesthesia and nerve blocks, seek expert\r\nadvice", "Surface anaesthesia, see preparations below", "The licensed doses stated above may not be appropriate in some\r\nsettings and expert advice should be sought", "Up to 3 plasters may be used to cover large\r\nareas; plasters may be cut", "Name[Versatis\u00ae (Gr\u00fcnenthal) ] Plasters, lidocaine\r\n5% (700\u00a0mg/medicated plaster), net price 30 = \u00a372.40Excipients  include hydroxybenzoates\r\n(parabens), propylene glycolDose\u00a0postherpetic neuralgia, adult over 18 years, apply to intact, dry, non-hairy, non-irritated skin\r\nonce daily for up to 12 hours, followed by a 12-hour plaster-free\r\nperiod; discontinue if no response after 4 weeksNote\u00a0Up to 3 plasters may be used to cover large\r\nareas; plasters may be cutNote\u00a0The Scottish Medicines\r\nConsortium has advised (July 2008) that Versatis\u00ae is accepted\r\nfor restricted use within NHS Scotland for the treatment of postherpetic\r\nneuralgia in patients who are intolerant of first-line systemic therapies\r\nor when they have been ineffective"], "pregnancy": "Pregnancy\u00a0large doses can cause fetal bradycardia; large doses\r\nduring delivery can cause neonatal respiratory depression, hypotonia,\r\nor bradycardia after paracervical or epidural block"}, {"indications": "Indications\u00a0see under Dose; ventricular arrhythmias\r\n(section 2.3.2); eye (section 11.7); oral lesions (section 12.3.1)", "name": "LIDOCAINE HYDROCHLORIDE Lidocaine hydrochloride injections", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "15 Anaesthesia", "15.2 Local anaesthesia", "Lidocaine", "LIDOCAINE HYDROCHLORIDE", "Lidocaine hydrochloride injections"], "cautions": "Cautions\u00a0See Cautions of Local Anaesthetics and section 2.3.2; hypertension; topical preparations can damage plastic cuffs of endotracheal\r\ntubes", "side-effects": "Side-effects\u00a0see Toxicity and Side-effects and section 2.3.2; also methaemoglobinaemia (see\r\nunder Prilocaine for treatment), nystagmus, rash; hypoglycaemia\r\nalso reported following intrathecal or extradural administration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6688.htm", "doses": ["To avoid excessive dosage in obese patients,\r\ndose may need to be calculated on the basis of ideal body-weight", "Infiltration anaesthesia, according to patient\u2019s weight and\r\nnature of procedure, max. 200\u00a0mg (or 500\u00a0mg if given in solutions\r\ncontaining adrenaline)\u2014see also Administration and important warning below", "Intravenous regional anaesthesia and nerve blocks, seek expert\r\nadvice", "Surface anaesthesia, see preparations below", "The licensed doses stated above may not be appropriate in some\r\nsettings and expert advice should be sought", "Name[Lidocaine (Non-proprietary) ] Injection, lidocaine hydrochloride\r\n5\u00a0mg/mL (0.5%), net price 10-mL amp = 35p; 10\u00a0mg/mL (1%), 2-mL amp\r\n= 26p, 5-mL amp = 28p, 10-mL amp = 42p, 10-mL prefilled syringe =\r\n\u00a34.53; 20-mL amp = 71p; 20\u00a0mg/mL (2%), 2-mL amp = 33p, 5-mL amp =\r\n32p"], "pregnancy": "Pregnancy\u00a0large doses can cause fetal bradycardia; large doses\r\nduring delivery can cause neonatal respiratory depression, hypotonia,\r\nor bradycardia after paracervical or epidural block"}, {"indications": "Indications\u00a0ventricular arrhythmias, especially\r\nafter myocardial infarction; eye (section 11.7); local anaesthesia (section 15.2)", "name": "LIDOCAINE HYDROCHLORIDE - VENTRICULAR ARRHYTHMIAS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.3 Anti-arrhythmic drugs", "2.3.2 Drugs for arrhythmias", "Ventricular arrhythmias"], "cautions": "Cautions\u00a0lower doses in congestive cardiac\r\nfailure and following cardiac surgery; monitor ECG and have resuscitation facilities\r\navailable; elderly; interactions: Appendix 1 (lidocaine)", "side-effects": "Side-effects\u00a0dizziness, paraesthesia, or drowsiness (particularly\r\nif injection too rapid); other CNS effects include confusion, respiratory\r\ndepression and convulsions; hypotension and bradycardia (may lead\r\nto cardiac arrest); rarely hypersensitivity reactions\r\nincluding anaphylaxis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2441.htm", "doses": ["By intravenous injection, in patients without\r\ngross circulatory impairment, 100\u00a0mg as a bolus over a few minutes\r\n(50\u00a0mg in lighter patients or those whose circulation is severely\r\nimpaired), followed immediately by infusion of 4\u00a0mg/minute\r\nfor 30 minutes, 2\u00a0mg/minute for 2 hours, then 1\u00a0mg/minute; reduce\r\nconcentration further if infusion continued beyond 24 hours (ECG monitoring\r\nand specialist advice for infusion)", "Following intravenous injection lidocaine has a short duration of action (lasting for 15\u201320 minutes).\r\nIf an intravenous infusion is not immediately available\r\nthe initial intravenous injection of 50\u2013100\u00a0mg can\r\nbe repeated if necessary once or twice at intervals of not less than\r\n10 minutes"], "pregnancy": "Pregnancy\u00a0crosses the placenta but not known to be harmful\r\nin animal studies\u2014use if benefit outweighs risk"}, {"indications": "Indications\u00a0see under Dose; ventricular arrhythmias\r\n(section 2.3.2); eye (section 11.7); oral lesions (section 12.3.1)", "name": "LIDOCAINE HYDROCHLORIDE - LIDOCAINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "15 Anaesthesia", "15.2 Local anaesthesia", "Lidocaine", "LIDOCAINE HYDROCHLORIDE"], "cautions": "Cautions\u00a0See Cautions of Local Anaesthetics and section 2.3.2; hypertension; topical preparations can damage plastic cuffs of endotracheal\r\ntubes", "side-effects": "Side-effects\u00a0see Toxicity and Side-effects and section 2.3.2; also methaemoglobinaemia (see\r\nunder Prilocaine for treatment), nystagmus, rash; hypoglycaemia\r\nalso reported following intrathecal or extradural administration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6687.htm", "doses": ["To avoid excessive dosage in obese patients,\r\ndose may need to be calculated on the basis of ideal body-weight", "Infiltration anaesthesia, according to patient\u2019s weight and\r\nnature of procedure, max. 200\u00a0mg (or 500\u00a0mg if given in solutions\r\ncontaining adrenaline)\u2014see also Administration and important warning below", "Intravenous regional anaesthesia and nerve blocks, seek expert\r\nadvice", "Surface anaesthesia, see preparations below", "The licensed doses stated above may not be appropriate in some\r\nsettings and expert advice should be sought"], "pregnancy": "Pregnancy\u00a0large doses can cause fetal bradycardia; large doses\r\nduring delivery can cause neonatal respiratory depression, hypotonia,\r\nor bradycardia after paracervical or epidural block"}, {"indications": "Indications\u00a0see under Dose; ventricular arrhythmias\r\n(section 2.3.2); eye (section 11.7); oral lesions (section 12.3.1)", "name": "LIDOCAINE HYDROCHLORIDE With prilocaine", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "15 Anaesthesia", "15.2 Local anaesthesia", "Lidocaine", "LIDOCAINE HYDROCHLORIDE", "With prilocaine"], "cautions": "Cautions\u00a0See Cautions of Local Anaesthetics and section 2.3.2; hypertension; topical preparations can damage plastic cuffs of endotracheal\r\ntubes", "side-effects": "Side-effects\u00a0see Toxicity and Side-effects and section 2.3.2; also methaemoglobinaemia (see\r\nunder Prilocaine for treatment), nystagmus, rash; hypoglycaemia\r\nalso reported following intrathecal or extradural administration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6693.htm", "doses": ["To avoid excessive dosage in obese patients,\r\ndose may need to be calculated on the basis of ideal body-weight", "Infiltration anaesthesia, according to patient\u2019s weight and\r\nnature of procedure, max. 200\u00a0mg (or 500\u00a0mg if given in solutions\r\ncontaining adrenaline)\u2014see also Administration and important warning below", "Intravenous regional anaesthesia and nerve blocks, seek expert\r\nadvice", "Surface anaesthesia, see preparations below", "The licensed doses stated above may not be appropriate in some\r\nsettings and expert advice should be sought", "Shorter application time of 15\u201330 minutes\r\nis recommended for children with atopic dermatitis (30 minutes before\r\nremoval of mollusca)", "Name[EMLA\u00ae (AstraZeneca)] Cream, lidocaine 2.5%, prilocaine\r\n2.5%, net price 5-g tube = \u00a31.73; 30-g tube (surgical pack) = \u00a310.25;\r\n5 \u00d7 5-g tube with 12 occlusive dressings (premedication pack) = \u00a39.75Dose\u00a0adult and child over 1 year, anaesthesia before minor skin\r\nprocedures including venepuncture, apply thick layer under occlusive\r\ndressing 1\u20135 hours before procedure (2\u20135 hours before procedures on\r\nlarge areas e.g. split skin grafting); max. 2 doses in 24 hours for child 1\u201312 years; child under 3 months, apply max. 1\u00a0g under occlusive dressing for max.\r\n1 hour before procedure; max. 1 dose in 24 hours, child 3\u201312 months, apply max. 2\u00a0g under occlusive dressing for max. 4\r\nhours before procedure; max. 2 doses in 24 hoursNote\u00a0Shorter application time of 15\u201330 minutes\r\nis recommended for children with atopic dermatitis (30 minutes before\r\nremoval of mollusca)Anaesthesia on genital skin before injection of local\r\nanaesthetics, apply under occlusive dressing for 15 minutes (in adult\r\nmen) and 60 minutes (in adult women)Anaesthesia before surgical treatment of lesions on genital\r\nmucosa in adults, apply up to 10\u00a0g 5\u201310 minutes before procedureAnaesthesia before cervical curettage in adults, administer\r\n10\u00a0g in lateral vaginal fornices for 10 minutesAnaesthesia before mechanical cleansing or debridement\r\nof leg ulcer in adults, apply up to 10\u00a0g for 30\u201360 minutes"], "pregnancy": "Pregnancy\u00a0large doses can cause fetal bradycardia; large doses\r\nduring delivery can cause neonatal respiratory depression, hypotonia,\r\nor bradycardia after paracervical or epidural block"}, {"indications": "Indications\u00a0see under Dose; ventricular arrhythmias\r\n(section 2.3.2); eye (section 11.7); oral lesions (section 12.3.1)", "name": "LIDOCAINE HYDROCHLORIDE Lidocaine for ear, nose, and oropharyngeal use", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "15 Anaesthesia", "15.2 Local anaesthesia", "Lidocaine", "LIDOCAINE HYDROCHLORIDE", "Lidocaine for ear, nose, and oropharyngeal use"], "cautions": "Cautions\u00a0See Cautions of Local Anaesthetics and section 2.3.2; hypertension; topical preparations can damage plastic cuffs of endotracheal\r\ntubes", "side-effects": "Side-effects\u00a0see Toxicity and Side-effects and section 2.3.2; also methaemoglobinaemia (see\r\nunder Prilocaine for treatment), nystagmus, rash; hypoglycaemia\r\nalso reported following intrathecal or extradural administration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/74859.htm", "doses": ["To avoid excessive dosage in obese patients,\r\ndose may need to be calculated on the basis of ideal body-weight", "Infiltration anaesthesia, according to patient\u2019s weight and\r\nnature of procedure, max. 200\u00a0mg (or 500\u00a0mg if given in solutions\r\ncontaining adrenaline)\u2014see also Administration and important warning below", "Intravenous regional anaesthesia and nerve blocks, seek expert\r\nadvice", "Surface anaesthesia, see preparations below", "The licensed doses stated above may not be appropriate in some\r\nsettings and expert advice should be sought", "Name[Lidocaine with phenylephrine (Non-proprietary)] Topical solution, lidocaine hydrochloride\r\n5%, phenylephrine hydrochloride 0.5%, net price\r\n2.5\u00a0mL (with nasal applicator) = \u00a39.98Dose\u00a0anaesthesia before nasal surgery, endoscopy, laryngoscopy,\r\nor removal of foreign bodies from the nose, adult and child over 12 years, up to max.\r\n8 sprays"], "pregnancy": "Pregnancy\u00a0large doses can cause fetal bradycardia; large doses\r\nduring delivery can cause neonatal respiratory depression, hypotonia,\r\nor bradycardia after paracervical or epidural block"}, {"indications": "Indications\u00a0see under Dose; ventricular arrhythmias\r\n(section 2.3.2); eye (section 11.7); oral lesions (section 12.3.1)", "name": "LIDOCAINE HYDROCHLORIDE With adrenaline", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "15 Anaesthesia", "15.2 Local anaesthesia", "Lidocaine", "LIDOCAINE HYDROCHLORIDE", "With adrenaline"], "cautions": "Cautions\u00a0See Cautions of Local Anaesthetics and section 2.3.2; hypertension; topical preparations can damage plastic cuffs of endotracheal\r\ntubes", "side-effects": "Side-effects\u00a0see Toxicity and Side-effects and section 2.3.2; also methaemoglobinaemia (see\r\nunder Prilocaine for treatment), nystagmus, rash; hypoglycaemia\r\nalso reported following intrathecal or extradural administration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6690.htm", "doses": ["To avoid excessive dosage in obese patients,\r\ndose may need to be calculated on the basis of ideal body-weight", "Infiltration anaesthesia, according to patient\u2019s weight and\r\nnature of procedure, max. 200\u00a0mg (or 500\u00a0mg if given in solutions\r\ncontaining adrenaline)\u2014see also Administration and important warning below", "Intravenous regional anaesthesia and nerve blocks, seek expert\r\nadvice", "Surface anaesthesia, see preparations below", "The licensed doses stated above may not be appropriate in some\r\nsettings and expert advice should be sought", "Name[Xylocaine\u00ae (AstraZeneca) ] Injection, anhydrous lidocaine hydrochloride\r\n10\u00a0mg/mL (1%), adrenaline 1 in 200\u00a0000 (5\u00a0micrograms/mL), net price\r\n20-mL vial = 99p Excipients  include sulphites\nInjection, anhydrous lidocaine hydrochloride\r\n20\u00a0mg/mL (2%), adrenaline 1 in 200\u00a0000 (5\u00a0micrograms/mL), net price\r\n20-mL vial = \u00a31.37 Excipients  include sulphites"], "pregnancy": "Pregnancy\u00a0large doses can cause fetal bradycardia; large doses\r\nduring delivery can cause neonatal respiratory depression, hypotonia,\r\nor bradycardia after paracervical or epidural block"}]